Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Kyle Diamantas

Tracked across 10 events · 1560 articles · First seen Apr 16, 2026 · Last active Sep 07, 2026

Sentiment
6
Attention
9
Events
10
Relationships
18
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
6 10
Domestic
Impact: Kyle Diamantas will serve as the acting commissioner of the United States — Food and Drug Administration following Marty Makary's resignation, suggesting a potential shift in the agency's approach to various regulatory issues.
May 08, 2026 · 114 articles
4 -20
Domestic
Impact: Kyle Diamantas, the United States — Food and Drug Administration's deputy commissioner for foods, is tasked with developing a definition for 'ultra-processed foods' and is the first non-scientist to head the United States — Food and Drug Administration in over half a century, raising concerns among critics.
May 13, 2026 · 6 articles
4 10
Regulatory
Impact: As acting FDA Commissioner, Diamantas is the public face of the proposal, articulating its benefits for postmarket safety.
Aug 10, 2026 · 12 articles
4 10
Regulatory
On August 31, 2026, the United States — United States Securities and Exchange Commission (SEC) and the United States — Food and Drug Administration (FDA) signed a Memorandum of Understanding (MOU) establishing a formal framework…
Impact: As Acting FDA Commissioner, Diamantas signed the MOU, supporting transparency and cooperation with the SEC.
Aug 31, 2026 · 6 articles
6 10
Domestic
Impact: Diamantas has been acting FDA chief since May, providing some stability. His future role is uncertain under a new commissioner.
Aug 19, 2026 · 101 articles
4 0
Regulatory
Impact: Diamantas, acting FDA commissioner, may return to his previous deputy role; his tenure saw reversals on some drug approvals.
Aug 25, 2026 · 6 articles
7 -10
Accidents
Impact: Acting FDA Commissioner Kyle Diamantas announced the false-positive test result, which complicated the investigation.
Jul 08, 2026 · 358 articles
7 40
Regulatory
Impact: As acting FDA Commissioner, Diamantas sought to rebuild industry confidence after the controversies.
Aug 05, 2026 · 105 articles
7 10
Regulatory
Impact: As acting FDA Commissioner, Kyle Diamantas announced the approval, emphasizing the agency's duty to deliver treatments quickly, and oversaw the expedited review process.
Aug 26, 2026 · 92 articles
9 0
International
Impact: Kyle Diamantas is expected to take over as acting commissioner of the United States — Food and Drug Administration.
Apr 16, 2026 · 760 articles
Vinay Prasad ↔ Kyle Diamantas
Vinay Prasad ↔ Kyle Diamantas
Marty Makary successor ↔ Kyle Diamantas Kyle Diamantas served as the FDA deputy commissioner under Marty Makary. Followi
Marty Makary predecessor ↔ Kyle Diamantas Marty Makary led the FDA as commissioner with Kyle Diamantas serving as his depu
Robert F. Kennedy Jr. ↔ Kyle Diamantas
Robert F. Kennedy Jr. ↔ Kyle Diamantas
Donald Trump ↔ Kyle Diamantas
Donald Trump ↔ Kyle Diamantas
United States ↔ Kyle Diamantas
United States ↔ Kyle Diamantas
ERGEN INTELLIGENCE
Track Kyle Diamantas live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.